Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2015
DOI: 10.1128/jcm.00358-15
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a Real-Time Reverse Transcription-PCR Assay for Detection of Enterovirus D68 in Clinical Samples from an Outbreak in New York State in 2014

Abstract: An outbreak of severe respiratory illness associated with enterovirus D68 (EV-D68) infection was reported in mid-The EV-D68 rRT-PCR showed diagnostic sensitivity and specificity of 98.6% and 97.5%, respectively. Our data suggest that the EV-D68 rRT-PCR is a reliable assay for detection of EV-D68 in clinical samples and has a potential to be used as a tool for rapid diagnosis and outbreak investigation of EV-D68-associated infections in clinical and public health laboratories.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 18 publications
1
20
0
Order By: Relevance
“…Future research should be directed at improving the knowledge of EV-D68 epidemiology, disseminating specific EV-D68 laboratory tests [12,22], and identifying EV-D68-specific therapies. Prospective follow-up is needed to determine the long-term outcomes of children with EV-D68 infection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Future research should be directed at improving the knowledge of EV-D68 epidemiology, disseminating specific EV-D68 laboratory tests [12,22], and identifying EV-D68-specific therapies. Prospective follow-up is needed to determine the long-term outcomes of children with EV-D68 infection.…”
Section: Discussionmentioning
confidence: 99%
“…Prior to the development of real-time RT-PCR for EV-D68 [22], samples were sequenced based on the enterovirus VP1 region at the CDC [23]. Once an EV-D68-specific RT-PCR method was developed, the remaining samples were tested by RT-PCR only at CMH.…”
Section: Virologic Testingmentioning
confidence: 99%
“…An EV-D68-specific RT-PCR method was quickly developed by the CDC following the outbreak in 2014 and was approved by the Food and Drug Administration under emergency use authorization only. [39][40][41] Other RT-PCR methods, with different degrees of specificity and sensitivity, have also been developed [42][43][44] as well as a duplex-assay for simulations screening and differentiation between non-D68 EV positive and D68 positive virus. 45 Complete viral genomes of EV-D68 have been generated by high-throughput sequencing of overlapping amplicons from primary specimens, allowing for identification of new clades as well as by other whole-genome sequencing strategies.…”
Section: Ev-d68 Diagnosticsmentioning
confidence: 99%
“…Several cases of flaccid myelitis have been temporally related to EV-D68 infection but a causal role of EV-D68 has not been established. A new real-time RT-PCR test is available from the CDC (Zhuge et al, 2015). Three strains have been identified with 92% belonging to one strain, 7.4% to the second, and a single case of the third strain.…”
Section: Severe Illness Associated With Ev-d68 Infection In the Unitedmentioning
confidence: 99%